Lobbying: all issues, rounded to the nearest $10,000. Two filers, same 21 months. This PAC gives money raised from the company’s employees; the company itself can’t give to campaigns from its treasury.
Spend by quarter Pro
Free account See ProWhat they lobby on
MethodNeurocrine Biosciences reported federal lobbying in 8 of the last 8 quarters (Q4 2024 to Q3 2026), with its own in-house lobbyists and 5 outside firms. What follows is what the filings say it lobbied on, not which way.
Issue areas ranked by quarters filedQ4 24 → Q3 26
- Budget/Appropriations8/8
- Health Issues8/8
- Medicare/Medicaid8/8
- Pharmacy8/8
- Taxation/Internal Revenue Code8/8
Financial Institutions/Investments/Securities 1 of 8 · Show all 6
- Financial Institutions/Investments/Securities1/8
Bills named in the filings 13 bills, this period
- H.R. 1492 To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.7 filings
- H.R. 3432 TDS Research Act of 20257 filings
- H.R. 7024 Hemp Planting Predictability Act7 filings
- H.R. 7623 Freedom House Ambulance Service Congressional Gold Medal Act7 filings
- H.R. 946 ORPHAN Cures Act7 filings
8 more, 7 named in only one filing · Show all 13
- S. 832 EPIC Act of 20257 filings
- H.R. 3432, 118th Telemental Health Care Access Act of 20231 filing
- H.R. 5539, 118th ORPHAN Cures Act1 filing
- H.R. 7085, 118th BIOSECURE Act1 filing
- H.R. 7174, 118th To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.1 filing
- S. 2678, 118th Outbound Investment Transparency Act of 20231 filing
- H.R. 7024, 118th Tax Relief for American Families and Workers Act of 2024 Broad bill1 filing
- H.R. 7623, 118th Telehealth Modernization Act of 2024 Broad bill1 filing
From the filings
“Issues related to implementation of the Inflation Reduction Act, P.L. 117-169, including potential changes to the structure of and reimbursement for Medicare Part D. H.R. 946 - Orphan Cures Act H.R. 1492 / S. 832 - Ensuring Pathways to Innovative Cures (EPIC) Act Issues related to drug pricing”
“IRA, prescription drug pricing, payment reform, innovation”
Contacted as listed on the filings
- U.S. House
- U.S. Senate
- CMS
- HHS
- EOP
- White House Office
The House and Senate appear in every quarter; agencies in all 8 quarters.
Every filing since 2015 Pro
Free account See ProSource: Lobbying Disclosure Act filings (LD-2) by Neurocrine Biosciences, Senate Office of Public Records. Filings are due 20 days after each quarter ends.
From FEC filings: direct gifts this PAC reported, net of refunds · How we count
Gave directly to 31 sitting members of Congress and 1 other candidate in 2025–26.
See every candidate and member Neurocrine Biosciences gave to directly, how much, and how its money splits between the parties.
This part is in Pro. A free account lets you follow up to 3 people and get a weekly email about them; upgrade whenever you need more.
Create a free account See what Pro adds Log in